» Articles » PMID: 25408182

Quebec Integrated Chronic Disease Surveillance System (QICDSS), an Innovative Approach

Overview
Date 2014 Nov 20
PMID 25408182
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: With the growing burden of chronic diseases, surveillance will play an essential role in improving their prevention and control. The Institut national de santé publique du Québec has developed an innovative chronic disease surveillance system, the Quebec Integrated Chronic Disease Surveillance System (QICDSS). We discuss the primary features, strengths and limitations of this system in this report.

Methods: The QICDSS was created by linking five health administrative databases. Updated annually, it currently covers the period from January 1, 1996, to March 31, 2012. The operational model comprises three steps: (1) extraction and linkage of health administrative data according to specific selection criteria; (2) analysis (validation of case definitions essentially) and production of surveillance measures; and (3) data interpretation, submission and dissemination of information. The QICDSS allows the surveillance of the following chronic diseases: diabetes, cardiovascular diseases, respiratory diseases, osteoporosis, osteoarticular diseases, mental disorders, Alzheimer's disease and related disorders. The system also lends itself to the analysis of multimorbidity and polypharmacy.

Results: For 2011-2012, the QICDSS contained information on 7 995 963 Quebecers with an average age of 40.8 years. Of these, 95.3% met at least one selection criterion allowing the application of case definitions for chronic disease surveillance. The actual proportion varied with age, from 90.1% for those aged 19 years or less to 99.3% for those aged 65 years or over.

Conclusion: The QICDSS provides a way of producing population-based data on the chronic disease burden, health services and prescription drug uses. The system facilitates the integrated study of several diseases in combination, an approach rarely implemented until now in the context of population surveillance. The QICDSS possesses all the essential features of a surveillance system and supports the dissemination of information to public health decision-makers for future actions.

Citing Articles

Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event Outcomes.

Talbot D, Diop A, Mesidor M, Chiu Y, Sirois C, Spieker A Stat Med. 2025; 44(6):e70034.

PMID: 40079648 PMC: 11905698. DOI: 10.1002/sim.70034.


Profiles of physician follow-up care, correlates and outcomes among patients affected by an incident mental disorder.

Fleury M, Rochette L, Cao Z, Grenier G, Massamba V, Lesage A BMC Prim Care. 2025; 26(1):7.

PMID: 39799284 PMC: 11724569. DOI: 10.1186/s12875-024-02674-0.


Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada.

Campeau Calfat A, Turner J, Simard M, Boiteau V, Sirois C Ther Adv Drug Saf. 2024; 15:20420986241309882.

PMID: 39737141 PMC: 11683794. DOI: 10.1177/20420986241309882.


Cardiovascular diseases in Quebec health administrative databases: missing diagnoses and underestimation of the number of cases in a 28-year prospective cohort.

Lavigne-Robichaud M, Diffo E, Brisson C, Levesque M, Blanchette C, Milot A Health Promot Chronic Dis Prev Can. 2024; 44(10):409-416.

PMID: 39388292 PMC: 11542739. DOI: 10.24095/hpcdp.44.9.01.


Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohort.

Guay C, Maltais F, Beaudoin C, Carmichael P, Laouan Sidi E, Perreault L BMC Pulm Med. 2024; 24(1):450.

PMID: 39272042 PMC: 11401429. DOI: 10.1186/s12890-024-03277-2.